Inactive Instrument

IPI Legacy Liquidation Co Share Price

Equities

Duration

Period

Style

North American Morning Briefing : Big Banks Kick -2-	04-12	DJ
North American Morning Briefing : Investors on -2-	04-05	DJ
IPI Legacy Liquidation Co Went Out of Business	04-05	CI
Second Revised First Amended Liquidation Plan Approved for IPI Legacy Liquidation Co	04-02	CI
North American Morning Briefing : Stocks Struggle After New Records	03-22	DJ
Impel Pharmaceuticals Inc. has Changed its Name to IPI Legacy Liquidation Co	03-08	CI
Combined Disclosure Statement Conditionally Approved for Impel Pharmaceuticals Inc.	02-27	CI
First Amended Joint Liquidation Plan and Disclosure Statement Filed by Impel Pharmaceuticals Inc.	02-25	CI
Impel Pharmaceuticals Inc. Announces Departure of Len Paolillo as Interim Chief Executive Officer	02-14	CI
Joint Liquidation Plan and Disclosure Statement Filed by Impel Pharmaceuticals Inc.	02-12	CI
An undisclosed buyer completed the acquisition of substantially all assets of Impel Pharmaceuticals Inc. for $17.5 million.	02-11	CI
Motion for Asset Sale Approved for Impel Pharmaceuticals Inc.	02-02	CI
Notice of Winning Bidder Filed by Impel Pharmaceuticals Inc.	01-29	CI
Notice of Auction Cancellation Filed by Impel Pharmaceuticals Inc.	01-27	CI
Bidding Procedure Approved for Impel Pharmaceuticals Inc.	01-11	CI

12/05/23

North American Morning Briefing : Investors on -2-	04-05	DJ
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	11-20	DJ
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike	08/09/23	MT
JonesTrading Downgrades Impel Pharmaceuticals to Hold From Buy	18/08/23	MT
Wedbush Adjusts Impel Pharmaceuticals' Price Target to $2 From $4, Maintains Neutral Rating	24/03/23	MT

Impel Pharmaceuticals : ORDER (I) APPROVING NOTIFICATION AND HEARING PROCEDURES FOR CERTAIN TRANSFERS OF AND DECLARATION OF WORTHLESSNESS WITH RESPECT TO COMMON STOCK AND (II) GRANTING RELATED RELIEF - Form 8-K	01-02	PU
Impel Pharmaceuticals : Announces Filing Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale - Form 8-K	12-20	PU
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	05/10/23	GL
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	05/10/23	AQ
Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals?	05/07/23	PR

Managers	Title	Age	Since
John D. Hoekman FOU	Founder	43	31/12/07
Sheena Aurora CTO	Chief Tech/Sci/R&D Officer	-	-
Scott Youmans CTO	Chief Tech/Sci/R&D Officer	57	-

Members of the board	Title	Age	Since
Timothy Nelson BRD	Director/Board Member	60	31/01/17
Ali Satvat BRD	Director/Board Member	46	06/12/18
Diane Wilfong BRD	Director/Board Member	62	16/09/19

Name	Weight	AuM	1st Jan change	Investor Rating
LEVERAGE SHARES -3X SHORT BIOTECHNOLOGY ETP SECURITIES - USD	0.01%	0 M€	0.00%	-

IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesnât hold any assets.

Sector

Calendar

	1st Jan change	Capi.
MODERNA, INC.	+29.77%	49.46B
IQVIA HOLDINGS INC.	+1.00%	42.58B
LONZA GROUP AG	+49.39%	42.49B
CELLTRION, INC.	-5.26%	29.09B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.61B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.64B
BIO-TECHNE CORPORATION	+8.22%	13.16B
MEDPACE HOLDINGS, INC.	+32.41%	12.55B
UNITED THERAPEUTICS CORPORATION	+24.01%	12.1B